Jianmin Pharmaceutical Group Co.，Ltd.

The company was founded in the 10th year of Ming Chongzhen (1637). Formerly known as “Ye Kaitai”, it enjoyed the reputation of “Three Masters of the Early Qing Dynasty” and “China's Big Four Pharmaceutical Names” before liberation. In 1953, Ye Kaitai Pharmaceutical was partially transformed into “Wuhan Jianmin Pharmaceutical Factory” and listed on the Shanghai Stock Exchange in 2004. The company is mainly engaged in pharmaceutical R&D, manufacturing, wholesale and retail business, and is mainly divided into two major sectors: pharmaceutical industry and pharmaceutical business. Main products: Longmuzhuang bone granules, spleen and blood granules, Xiaojin capsules, bowel relief capsules, Jianmin throat tablets, estradiol gel. The company's honors include China's time-honored brand, the 45th most advanced unit in the top 100 Chinese pharmaceutical industry in 2002, the 2002 Quality Wanli Advanced Unit, the 2024 Health Industry Star Partner Award, the 2023 Top 50 Pharmaceutical Companies, the West Lake Award · Top 10 Pharmaceutical Manufacturing Digital Model Companies, and the 2024 Wuzhen Health Conference · VIP Strategic Cooperation Enterprise.